We’re proud to announce that PROphetNSCLC® is now officially approved for use in New York - completing our expansion across all 50 U.S. states. 🔗 Read the full announcement: https://t.co/ehwdusE2FE #CancerCare #AIinHealthcare #Proteomics

This Healthy Lung Month, we stand with patients, caregivers, and clinicians working to improve outcomes in lung cancer. At OncoHost, we’re proud to support innovation in blood-based testing to guide smarter, more personalized treatment decisions. #HealthyLungMonth #LungCancer

Join us at our #ESMO2025 poster presentation, where our VP of Translational Medicine, Dr. Michal Harel, will present new data on how plasma proteomics is redefining personalized cancer care in metastatic melanoma. 📍Poster Hall | 🕛 12:00 PM #PrecisionOncology #Proteomics

We’re excited to share that OncoHost will present new research at #ESMO2025 on using plasma proteomics to guide treatment selection in metastatic #melanoma. Read the full release here: https://t.co/CwX1IhQSrs #PrecisionOncology #Immunotherapy #Proteomics #CancerResearch

Did you know? Lung cancer is more treatable when caught early. During Healthy Lung Month, we encourage everyone at risk to talk to their doctor about low-dose CT scans and biomarker testing. Early answers save lives. #HealthyLungMonth #EarlyDetection #LungCancerAwareness

Are your lungs healthy? In honor of Healthy Lung Month, it’s the perfect time to check in on your respiratory health. Blood work (ABG, CBC, CMP), TB screening, and genetic checks can help assess your lung function and catch problems early. Read more:

October is Healthy Lung Month - a reminder to protect the lungs that protect you. From avoiding smoking to improving air quality and keeping up with screenings, small steps today can mean healthier lungs tomorrow. #HealthyLungMonth #LungHealth #Prevention

Only 16% of eligible people get lifesaving lung cancer screening, and too many start treatment without full biomarker testing. The @LungAssociation’s new campaign highlights why both are critical. Learn more:

Today is National Previvor Day 💙 We honor those taking proactive steps to reduce their cancer risk or do genetic testing, and the companies who are advancing technologies for early detection. #NationalPrevivorDay #NSCLC #previvor

PROphetNSCLC® provides insights to answer the question: Which first-line therapy is more likely to improve overall survival of the patient? With one blood draw, transform complex data into actionable guidance to deliver care that's truly individualized: https://t.co/j5sDret1Np

Big news in #EarlyDetection! Exact Sciences launched Cancerguard, a blood test that can detect signals from 50+ #cancer types, many with no current screening. At OncoHost, we’re excited to see even more innovation in blood-based technology. Read more:

Our recognition as Top Precision Oncology Solution for 2025 by Life Sciences Review continues to make waves! Read the full article here: https://t.co/Loc6ihbhH7 #PrecisionOncology #Proteomics #AI #CancerResearch

🌍 Air pollution and lung cancer: progress uneven across the globe A new study reveals that while PM2.5-related cancer deaths are declining in the U.S., Japan, and South Korea—China continues to carry a disproportionately high burden. https://t.co/bbAWkO2xxS #IndustryNews

🚀 Precision oncology is no longer just the future - it’s here today. At OncoHost, we’re combining proteomics + AI to give oncologists the actionable insights they need, right when it matters most. 👉 https://t.co/ZfEle4qK6Q #PrecisionOncology #Proteomics #AIinHealthcare

Our poster at #WCLC2025 in Barcelona! Using plasma proteomics, we identified 5 distinct #SCLC subtypes with unique biology & clinical outcomes—paving the way for more precise treatment strategies. #LungCancer #PrecisionOncology #Proteomics

Scenes from #WCLC2025 in Barcelona! 📸 Proud of our OncoHost team & thrilled to see Dr. David Gandara present our poster on SCLC subtypes identified by plasma proteomic analysis. #TeamOncoHost #PrecisionOncology #Proteomics

How can proteomics help overcome immunotherapy resistance in NSCLC? Dr. Adam Dicker, CMO @ OncoHost, shares insights on protein classifiers, therapy outcomes & personalized strategies. 👉 Watch here: https://t.co/MN1wC0iSFm #NSCLC #Proteomics #Oncology

We’re heading to #WCLC2025 in Barcelona! 🌍 OncoHost will present new #SCLC research using plasma proteomics to identify 5 subtypes with distinct biology & clinical outcomes. Full details: https://t.co/FSFwXkmhZx #Oncology #LungCancer #PrecisionMedicine

50 years of progress in thoracic oncology: from no clear path to treat lung cancer to molecular & proteomic profiling, CT screening, liquid biopsy, & more. Each breakthrough improves survival & outcomes. #IASLC reflects on five decades of milestones:

Happy Labor Day to our US-based team and partners! We hope your weekend has been filled with celebration, relaxation, and a shared sense of gratitude 🌞 #laborday #LDW #labordayweekend #happylaborday